With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting Spinal Ependymoma and Other Gliomas Using Novel Genetically Defined Models||The Johns Hopkins University School of Medicine / Charles Eberhart, MD, PhD||Catalyst Grants||2019||Maryland|
|Targeting symmetric division in pediatric cancers||Dana-Farber Cancer Institute / Rosalind Segal, MD/PhD||Innovation Grants||2019||Massachusetts|
|Targeting TGFb Pathway Dependencies in Group 3 Medullobastoma||University of California San Francisco / Zulekha Qadeer, PhD||Young Investigator Grants||2019||California|
|Targeting the Surface-ome of Embryonal Brain Tumors||Institut Curie / Olivier Ayrault, PhD||Crazy 8 Initiative||2019|
|Targeting Valine-Specific Amino Acid Dependency -in T-Cell Acute Lymphoblastic Leukemia||New York University Medical Center / Palaniraja Thandapani, PhD||Young Investigator Grants||2019||New York|
|The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma||Emory University / Anna Kenney, PhD & Dolores Hambardzumyan, PhD||Innovation Grants||2019||Georgia|
|The Impact Of CD56neg NK Cells in the Pathogenesis of Endemic Burkitt Lymphoma||University of Massachusetts Medical School / Catherine Forconi, PhD||Young Investigator Grants||2019||Massachusetts|
|The Role of Germline Variants in Infant Leukemogenesis||Washington University / Margaret Ferris, MD/PhD||Young Investigator Grants||2019||Missouri|
|The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia||Children's Hospital & Research Center at Oakland / Cheryl Peretz, MD||Young Investigator Grants||2019||California|
|The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade||University of Florida / Catherine Flores, PhD||Innovation Grants||2019||Florida|